AUB ScholarWorks

Exposure rates to hepatitis C and G virus infections among HIV-infected patients: Evidence of efficient transmission of HGV by the sexual route

Show simple item record

dc.contributor.author Ramia S.
dc.contributor.author Mokhbat J.
dc.contributor.author Sibai A.
dc.contributor.author Klayme S.
dc.contributor.author Naman R.
dc.contributor.editor
dc.date 2004
dc.date.accessioned 2017-10-05T15:37:18Z
dc.date.available 2017-10-05T15:37:18Z
dc.date.issued 2004
dc.identifier 10.1258/0956462041211180
dc.identifier.isbn
dc.identifier.issn 09564624
dc.identifier.uri http://hdl.handle.net/10938/15617
dc.description.abstract The importance of sexual transmission in the epidemiology of hepatitis G virus (HGV) and hepatitis C virus (HCV) was evaluated in two groups of HIV-1-positive Lebanese patients. Members of one group (90 patients) were HIV-1-infected via sexual route and denied intravenous drug (IVD) use, while members of the other group (28 patients) became HIV-1-infected parenterally and confessed frequent IVD use. The overall prevalence of HGV infection was relatively high in both groups and with no statistically significant difference between them (28percent among IVD users vs 32percent among the non-IVD users) despite the fact that non-IVD users were significantly older (32.7 ± 1.7 years) than the IVD users (24.0 ± 1.4 years) (P 0.01). Conversely, there was a clear association between IVD use and HCV infection (25percent for IVD users vs 7percent for non-IVD users) despite the significantly lower age of the IVD users. These results point to the efficient transmission of HGV via the sexual route, while the transmission of HCV is mainly via the parenteral route. CD4+ lymphocyte counts were known on only 82 HIV-1-infected patients. Although the number of HGV-RNA-positive patients (three) was small compared with anti-HGV-positive patients (24), a relationship was not found between CD4+ lymphocyte counts and the presence of HGV-RNA in the HIV-1-positive patients. The role of HGV in causing significant liver disease is still under dispute.
dc.format.extent
dc.format.extent Pages: (463-466)
dc.language English
dc.publisher LONDON
dc.relation.ispartof Publication Name: International Journal of STD and AIDS; Publication Year: 2004; Volume: 15; no. 7; Pages: (463-466);
dc.relation.ispartofseries
dc.relation.uri
dc.source Scopus
dc.subject.other
dc.title Exposure rates to hepatitis C and G virus infections among HIV-infected patients: Evidence of efficient transmission of HGV by the sexual route
dc.type Article
dc.contributor.affiliation Ramia, S., Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon
dc.contributor.affiliation Mokhbat, J., Rizk Hospital, Beirut, Lebanon
dc.contributor.affiliation Sibai, A., Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon
dc.contributor.affiliation Klayme, S., Hôtel Dieu de France Hospital, Beirut, Lebanon
dc.contributor.affiliation Naman, R., Hôtel Dieu de France Hospital, Beirut, Lebanon
dc.contributor.authorAddress Ramia, S.; Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon
dc.contributor.authorCorporate University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Internal Medicine;
dc.contributor.authorDepartment Internal Medicine
dc.contributor.authorDivision
dc.contributor.authorEmail
dc.contributor.authorFaculty Faculty of Medicine
dc.contributor.authorInitials Ramia, S
dc.contributor.authorInitials Mokhbat, J
dc.contributor.authorInitials Sibai, A
dc.contributor.authorInitials Klayme, S
dc.contributor.authorInitials Naman, R
dc.contributor.authorOrcidID
dc.contributor.authorReprintAddress Ramia, S (reprint author), Amer Univ Beirut, Fac Hlth Sci, Beirut, Lebanon.
dc.contributor.authorResearcherID
dc.contributor.authorUniversity American University of Beirut Medical Center
dc.description.cited Aikawa T, 1996, NEW ENGL J MED, V334, P195, DOI 10.1056-NEJM199601183340316; AlFaleh FZ, 1997, ANN SAUDI MED, V17, P77; Alter HJ, 1996, NEW ENGL J MED, V334, P1536, DOI 10.1056-NEJM199606063342310; Alter HJ, 1997, NEW ENGL J MED, V336, P747, DOI 10.1056-NEJM199703133361102; [Anonymous], 1997, HEPATOLOGY S1, V26, p2S; Dille BJ, 1997, J INFECT DIS, V175, P458; Fan XF, 1999, J MED VIROL, V58, P160, DOI 10.1002-(SICI)1096-9071(199906)58:2160::AID-JMV103.0.CO;2-9; Feucht HH, 1996, LANCET, V347, P615; Goubau P, 1999, J MED VIROL, V57, P367, DOI 10.1002-(SICI)1096-9071(199904)57:4367::AID-JMV73.0.CO;2-3; Gutierrez RA, 1997, J MED VIROL, V53, P167, DOI 10.1002-(SICI)1096-9071(199710)53:2167::AID-JMV103.0.CO;2-G; Ibanez A, 1998, J MED VIROL, V55, P293, DOI 10.1002-(SICI)1096-9071(199808)55:4293::AID-JMV73.0.CO;2-W; Lampe E, 1998, J MED VIROL, V56, P39, DOI 10.1002-(SICI)1096-9071(199809)56:139::AID-JMV73.3.CO;2-Y; Leary TP, 1996, J MED VIROL, V48, P60, DOI 10.1002-(SICI)1096-9071(199601)48:160::AID-JMV103.0.CO;2-A; LEFRERE JJ, 1997, BLOOD, V90, P2776; Linnen J, 1996, SCIENCE, V271, P505, DOI 10.1126-science.271.5248.505; Masuko K, 1996, NEW ENGL J MED, V334, P1485, DOI 10.1056-NEJM199606063342301; Mushahwar IK, 1998, J MED VIROL, V56, P1, DOI 10.1002-(SICI)1096-9071(199809)56:11::AID-JMV13.0.CO;2-3; Naman R E, 1996, J Med Liban, V44, P4; Nubling CM, 1997, J MED VIROL, V53, P218; Ramia S, 2002, ANN TROP MED PARASIT, V96, P197, DOI 10.1179-000349802125000439; Rezza G, 1996, SCAND J INFECT DIS, V28, P27, DOI 10.3109-00365549609027145; Scallan MF, 1998, J MED VIROL, V55, P203, DOI 10.1002-(SICI)1096-9071(199807)55:3203::AID-JMV43.0.CO;2-5; Schmidt B, 1996, LANCET, V347, P909, DOI 10.1016-S0140-6736(96)91396-3; Semprini AE, 1998, J INFECT DIS, V177, P848; Stark K, 1996, J INFECT DIS, V174, P1320; *STAT CORP, 1995, STAT STATSOFTW REL 4; Tacke M, 1997, LANCET, V349, P318, DOI 10.1016-S0140-6736(96)06461-6; Trisler Z, 1999, SCAND J INFECT DIS, V31, P33; Wu JC, 1997, J MED VIROL, V52, P83
dc.description.citedCount 9
dc.description.citedTotWOSCount 10
dc.description.citedWOSCount 10
dc.format.extentCount 4
dc.identifier.articleNo
dc.identifier.coden INSAE
dc.identifier.pubmedID 15228731
dc.identifier.scopusID 3242719504
dc.identifier.url
dc.publisher.address 1 WIMPOLE STREET, LONDON W1G 0AE, ENGLAND
dc.relation.ispartofConference
dc.relation.ispartofConferenceCode
dc.relation.ispartofConferenceDate
dc.relation.ispartofConferenceHosting
dc.relation.ispartofConferenceLoc
dc.relation.ispartofConferenceSponsor
dc.relation.ispartofConferenceTitle
dc.relation.ispartofFundingAgency
dc.relation.ispartOfISOAbbr Int. J. STD AIDS
dc.relation.ispartOfIssue 7
dc.relation.ispartOfPart
dc.relation.ispartofPubTitle International Journal of STD and AIDS
dc.relation.ispartofPubTitleAbbr Int. J. STD AIDS
dc.relation.ispartOfSpecialIssue
dc.relation.ispartOfSuppl
dc.relation.ispartOfVolume 15
dc.source.ID WOS:000222738300007
dc.type.publication Journal
dc.subject.otherAuthKeyword Hepatitis C virus
dc.subject.otherAuthKeyword Hepatitis G virus
dc.subject.otherAuthKeyword Human immunodeficiency virus
dc.subject.otherAuthKeyword Intravenous drug users
dc.subject.otherAuthKeyword Sexual transmission
dc.subject.otherChemCAS RNA, Viral
dc.subject.otherIndex virus RNA
dc.subject.otherIndex adult
dc.subject.otherIndex article
dc.subject.otherIndex controlled study
dc.subject.otherIndex female
dc.subject.otherIndex hepatitis C
dc.subject.otherIndex hepatitis G
dc.subject.otherIndex human
dc.subject.otherIndex Human immunodeficiency virus 1
dc.subject.otherIndex Human immunodeficiency virus infection
dc.subject.otherIndex intravenous drug abuse
dc.subject.otherIndex Lebanon
dc.subject.otherIndex liver disease
dc.subject.otherIndex lymphocyte count
dc.subject.otherIndex major clinical study
dc.subject.otherIndex male
dc.subject.otherIndex prevalence
dc.subject.otherIndex priority journal
dc.subject.otherIndex sexual intercourse
dc.subject.otherIndex virus transmission
dc.subject.otherIndex Adult
dc.subject.otherIndex Age Distribution
dc.subject.otherIndex CD4 Lymphocyte Count
dc.subject.otherIndex Female
dc.subject.otherIndex Flaviviridae Infections
dc.subject.otherIndex GB virus C
dc.subject.otherIndex Hepatitis, Viral, Human
dc.subject.otherIndex HIV Infections
dc.subject.otherIndex HIV-1
dc.subject.otherIndex Humans
dc.subject.otherIndex Lebanon
dc.subject.otherIndex Male
dc.subject.otherIndex Middle Aged
dc.subject.otherIndex Prevalence
dc.subject.otherIndex RNA, Viral
dc.subject.otherIndex Sexual Behavior
dc.subject.otherIndex Substance Abuse, Intravenous
dc.subject.otherKeywordPlus INJECTING DRUG-USERS
dc.subject.otherKeywordPlus CLINICAL-IMPLICATIONS
dc.subject.otherKeywordPlus GBV-C-HGV
dc.subject.otherKeywordPlus PREVALENCE
dc.subject.otherKeywordPlus TRANSFUSION
dc.subject.otherKeywordPlus ANTIBODIES
dc.subject.otherKeywordPlus RISK
dc.subject.otherKeywordPlus RNA
dc.subject.otherKeywordPlus SEROPREVALENCE
dc.subject.otherKeywordPlus GENOTYPES
dc.subject.otherWOS Immunology
dc.subject.otherWOS Infectious Diseases


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search AUB ScholarWorks


Browse

My Account